Zachariah Mciver serves as Chief Medical Officer at Janux Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Zachariah Mciver has executed 3 insider transactions totaling $37.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 101,500 shares valued at $0.
Zachariah Mciver currently holds 101,500 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Zachariah Mciver has been a net seller of JANX stock. They have purchased $0 and sold $37.3K worth of shares.
Zachariah Mciver's most recent insider trade was on Jan 2, 2026, when they sold 101,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 2, 2026 | JANX | $37.3K | Sale | 2,714 | $13.73 | Discretionary |